Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

Carol O. Tacket, Sandra M. Kelly, Florian Schödel, Genevieve Losonsky, James P. Nataro, Robert Edelman, Myron M. Levine, Roy Curtiss

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Attenuated Salmonella typhi organisms which express genes encoding protective antigens of other pathogens have been developed for use as experimental oral vaccines. A Δasd S. typhi strain attenuated by deletions in cya, crp, and cdt which contains hepatitis B core (HBc) and pre-S genes encoded on an Asd+ pBR-based plasmid vector was constructed. Healthy adult volunteers ingested a single dose of 5 x 105 to 5 x 108 CFU of strain χ4073 (Δcya Δcrp Δcdt S. typhi Ty2), 6 x 107 or 1 x 109 CFU of strain χ4632(pYA3149), a further derivative of χ4073 deleted in asd and containing the Asd+ vector without the HBc-pre-S fusion, or 3 x 107 or 7 x 108 CFU of strain χ4632(pYA3167), a derivative containing the vector with the HBc-pre- S fusion. χ4073 was generally well tolerated by 22 volunteers. No volunteer had fever or positive blood cultures; 4 of 22 volunteers shed vaccine organisms in the stool in the first 48 h only. Two of 18 volunteers who received one of the plasmid-containing derivatives of χ4073 developed low- grade fevers on day 10 or 12 after ingestion. One of these volunteers had positive blood cultures on days 7 and 8. Seven of these 18 volunteers had vaccine organisms detected in their stools in the first 48 h only. Most volunteers developed S. typhi-specific serum responses and developed S. typhi-specific antibody-secreting cells. However, no volunteer developed serum antibody to hepatitis pre-S or pre-S-specific antibody-secreting cells. Although the parent strain χ4073 was well tolerated, induced immunoglobulin G seroconversion to S. typhi lipopolysaccharide in 80 to 100% of vaccinees and stimulated specific IgA-secreting lymphocytes in 80 to 100% of vaccinees given a single oral dose of 2 x 107 and 5 x 108 CFU, χ4073 derivatives containing the Asd+ vector with and without sequences encoding the HBc-pre- S fusion caused occasional febrile reactions at high doses and did not stimulate detectable immune responses to hepatitis B antigens.

Original languageEnglish (US)
Pages (from-to)3381-3385
Number of pages5
JournalInfection and Immunity
Volume65
Issue number8
StatePublished - 1997
Externally publishedYes

Fingerprint

Salmonella Vaccines
Hepatitis B Antigens
Attenuated Vaccines
Salmonella typhi
Volunteers
Plasmids
Safety
Hepatitis B
Antibody-Producing Cells
Fever
Vaccines
Hepatitis Antibodies
Serum
Immunoglobulin A
Genes
Lipopolysaccharides
Healthy Volunteers
Eating
Immunoglobulin G
Lymphocytes

ASJC Scopus subject areas

  • Immunology

Cite this

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. / Tacket, Carol O.; Kelly, Sandra M.; Schödel, Florian; Losonsky, Genevieve; Nataro, James P.; Edelman, Robert; Levine, Myron M.; Curtiss, Roy.

In: Infection and Immunity, Vol. 65, No. 8, 1997, p. 3381-3385.

Research output: Contribution to journalArticle

Tacket, Carol O. ; Kelly, Sandra M. ; Schödel, Florian ; Losonsky, Genevieve ; Nataro, James P. ; Edelman, Robert ; Levine, Myron M. ; Curtiss, Roy. / Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system. In: Infection and Immunity. 1997 ; Vol. 65, No. 8. pp. 3381-3385.
@article{87d51b9400c244868c566cd7f61f7f77,
title = "Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system",
abstract = "Attenuated Salmonella typhi organisms which express genes encoding protective antigens of other pathogens have been developed for use as experimental oral vaccines. A Δasd S. typhi strain attenuated by deletions in cya, crp, and cdt which contains hepatitis B core (HBc) and pre-S genes encoded on an Asd+ pBR-based plasmid vector was constructed. Healthy adult volunteers ingested a single dose of 5 x 105 to 5 x 108 CFU of strain χ4073 (Δcya Δcrp Δcdt S. typhi Ty2), 6 x 107 or 1 x 109 CFU of strain χ4632(pYA3149), a further derivative of χ4073 deleted in asd and containing the Asd+ vector without the HBc-pre-S fusion, or 3 x 107 or 7 x 108 CFU of strain χ4632(pYA3167), a derivative containing the vector with the HBc-pre- S fusion. χ4073 was generally well tolerated by 22 volunteers. No volunteer had fever or positive blood cultures; 4 of 22 volunteers shed vaccine organisms in the stool in the first 48 h only. Two of 18 volunteers who received one of the plasmid-containing derivatives of χ4073 developed low- grade fevers on day 10 or 12 after ingestion. One of these volunteers had positive blood cultures on days 7 and 8. Seven of these 18 volunteers had vaccine organisms detected in their stools in the first 48 h only. Most volunteers developed S. typhi-specific serum responses and developed S. typhi-specific antibody-secreting cells. However, no volunteer developed serum antibody to hepatitis pre-S or pre-S-specific antibody-secreting cells. Although the parent strain χ4073 was well tolerated, induced immunoglobulin G seroconversion to S. typhi lipopolysaccharide in 80 to 100{\%} of vaccinees and stimulated specific IgA-secreting lymphocytes in 80 to 100{\%} of vaccinees given a single oral dose of 2 x 107 and 5 x 108 CFU, χ4073 derivatives containing the Asd+ vector with and without sequences encoding the HBc-pre- S fusion caused occasional febrile reactions at high doses and did not stimulate detectable immune responses to hepatitis B antigens.",
author = "Tacket, {Carol O.} and Kelly, {Sandra M.} and Florian Sch{\"o}del and Genevieve Losonsky and Nataro, {James P.} and Robert Edelman and Levine, {Myron M.} and Roy Curtiss",
year = "1997",
language = "English (US)",
volume = "65",
pages = "3381--3385",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

AU - Tacket, Carol O.

AU - Kelly, Sandra M.

AU - Schödel, Florian

AU - Losonsky, Genevieve

AU - Nataro, James P.

AU - Edelman, Robert

AU - Levine, Myron M.

AU - Curtiss, Roy

PY - 1997

Y1 - 1997

N2 - Attenuated Salmonella typhi organisms which express genes encoding protective antigens of other pathogens have been developed for use as experimental oral vaccines. A Δasd S. typhi strain attenuated by deletions in cya, crp, and cdt which contains hepatitis B core (HBc) and pre-S genes encoded on an Asd+ pBR-based plasmid vector was constructed. Healthy adult volunteers ingested a single dose of 5 x 105 to 5 x 108 CFU of strain χ4073 (Δcya Δcrp Δcdt S. typhi Ty2), 6 x 107 or 1 x 109 CFU of strain χ4632(pYA3149), a further derivative of χ4073 deleted in asd and containing the Asd+ vector without the HBc-pre-S fusion, or 3 x 107 or 7 x 108 CFU of strain χ4632(pYA3167), a derivative containing the vector with the HBc-pre- S fusion. χ4073 was generally well tolerated by 22 volunteers. No volunteer had fever or positive blood cultures; 4 of 22 volunteers shed vaccine organisms in the stool in the first 48 h only. Two of 18 volunteers who received one of the plasmid-containing derivatives of χ4073 developed low- grade fevers on day 10 or 12 after ingestion. One of these volunteers had positive blood cultures on days 7 and 8. Seven of these 18 volunteers had vaccine organisms detected in their stools in the first 48 h only. Most volunteers developed S. typhi-specific serum responses and developed S. typhi-specific antibody-secreting cells. However, no volunteer developed serum antibody to hepatitis pre-S or pre-S-specific antibody-secreting cells. Although the parent strain χ4073 was well tolerated, induced immunoglobulin G seroconversion to S. typhi lipopolysaccharide in 80 to 100% of vaccinees and stimulated specific IgA-secreting lymphocytes in 80 to 100% of vaccinees given a single oral dose of 2 x 107 and 5 x 108 CFU, χ4073 derivatives containing the Asd+ vector with and without sequences encoding the HBc-pre- S fusion caused occasional febrile reactions at high doses and did not stimulate detectable immune responses to hepatitis B antigens.

AB - Attenuated Salmonella typhi organisms which express genes encoding protective antigens of other pathogens have been developed for use as experimental oral vaccines. A Δasd S. typhi strain attenuated by deletions in cya, crp, and cdt which contains hepatitis B core (HBc) and pre-S genes encoded on an Asd+ pBR-based plasmid vector was constructed. Healthy adult volunteers ingested a single dose of 5 x 105 to 5 x 108 CFU of strain χ4073 (Δcya Δcrp Δcdt S. typhi Ty2), 6 x 107 or 1 x 109 CFU of strain χ4632(pYA3149), a further derivative of χ4073 deleted in asd and containing the Asd+ vector without the HBc-pre-S fusion, or 3 x 107 or 7 x 108 CFU of strain χ4632(pYA3167), a derivative containing the vector with the HBc-pre- S fusion. χ4073 was generally well tolerated by 22 volunteers. No volunteer had fever or positive blood cultures; 4 of 22 volunteers shed vaccine organisms in the stool in the first 48 h only. Two of 18 volunteers who received one of the plasmid-containing derivatives of χ4073 developed low- grade fevers on day 10 or 12 after ingestion. One of these volunteers had positive blood cultures on days 7 and 8. Seven of these 18 volunteers had vaccine organisms detected in their stools in the first 48 h only. Most volunteers developed S. typhi-specific serum responses and developed S. typhi-specific antibody-secreting cells. However, no volunteer developed serum antibody to hepatitis pre-S or pre-S-specific antibody-secreting cells. Although the parent strain χ4073 was well tolerated, induced immunoglobulin G seroconversion to S. typhi lipopolysaccharide in 80 to 100% of vaccinees and stimulated specific IgA-secreting lymphocytes in 80 to 100% of vaccinees given a single oral dose of 2 x 107 and 5 x 108 CFU, χ4073 derivatives containing the Asd+ vector with and without sequences encoding the HBc-pre- S fusion caused occasional febrile reactions at high doses and did not stimulate detectable immune responses to hepatitis B antigens.

UR - http://www.scopus.com/inward/record.url?scp=0030758117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030758117&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 3381

EP - 3385

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 8

ER -